Justine Calazan Manalastas

DMD | Dentist



  
  5504 E 22nd St Ste 140, Tucson
  Arizona, 85711-5586

  520-777-0790    Maps & Directions
Justine Calazan Manalastas is a Tucson, Arizona based Dentist who is specialized in Dentistry. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 5504 E 22nd St Ste 140, Tucson. Patients can reach her at 520-777-0790.
Justine Calazan Manalastas is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Justine Calazan Manalastas speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Justine Calazan Manalastas
Specialization: Dentist
Gender:Female
Credentials: DMD
Accepts Medicare Assignment:May Accept
Practice Address:5504 E 22nd St Ste 140, Tucson,
Arizona, 85711-5586
Phone:520-777-0790
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 3779889985
Enrollment ID: I20160315001533
NPI Number: 1174879449
NPI Enumeration Date: 24 Jul, 2012
NPI Last Update On: 24 Jul, 2012

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 5504 E 22nd St Ste 140,
Tucson, Arizona
Zip: 85711-5586
Phone Number: 520-777-0790
Patients can reach Justine Calazan Manalastas at 5504 E 22nd St Ste 140, Tucson, Arizona or can call to book an appointment on 520-777-0790. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.

Comments/ Reviews: